ALS (Motor Neuron Disease) Causes
ALS (Motor Neuron Disease) Causes
The most honest answer to what causes ALS is that no single cause has been established, and most people who develop it have no identifiable reason. What is known is considerable: several mechanisms that damage motor neurons have been identified, genes account for a proportion of cases, and the great majority occur without a family history. This page separates what is established from what has merely been studied, because the difference matters when someone is looking for an explanation.
What happens to a motor neuron
A motor neuron is a large, long, metabolically expensive cell: it maintains an axon that can be a metre long, it fires repeatedly, and it supports the machinery of a muscle at the far end. That size is also its vulnerability. ALS is what happens when several of the systems keeping such a cell alive begin to fail at once.
| Mechanism | What goes wrong |
|---|---|
| Glutamate excitotoxicity | Glutamate is the chemical that carries the signal between neurons. If it is not cleared promptly after firing, the receiving cell is over-stimulated to the point of injury. Reduced clearance is one of the earliest findings in ALS, and riluzole was developed against it |
| Oxidative stress | High metabolism produces reactive molecules that damage proteins, fats and DNA. The cell's defences against them are impaired in ALS, including through variants in the enzyme SOD1 |
| Mitochondrial failure | The cell's power supply deteriorates, which matters most at the far end of a very long axon where the energy demand is greatest |
| Protein aggregation | TDP-43, a protein that normally lives in the nucleus and handles RNA, is misplaced into the cytoplasm and clumps there in most cases of ALS. Its normal function is lost at the same time |
| Impaired RNA processing | Several of the genes implicated in ALS — C9orf72, TDP-43, FUS — are involved in handling RNA. Faulty processing is a recurring theme rather than a coincidence |
| Axonal transport failure | Materials have to travel the length of the axon. When transport fails, the far end starves first, which is consistent with the disease beginning distally |
| Glial and inflammatory change | The support cells around neurons are not passive. Their behaviour changes in ALS, and whether this drives the injury or responds to it is one of the open questions |
What matters about that list is that it is a list. These processes interact and amplify one another rather than running in parallel, which is part of why a treatment aimed at one of them has been modest in its effect. It is also why research has moved towards combinations.
The genetic contribution
Genes are the clearest thing known about cause, and they account for only part of the picture.
| Category | What it means |
|---|---|
| Familial ALS | A minority of cases, in which the disease runs in a family. Several genes have been identified — SOD1, C9orf72, FUS and TARDBP among the best known — and others remain unidentified |
| Sporadic ALS | The majority. No family history, and usually no single variant found. This does not mean genes are irrelevant, only that a single causal variant is not identified |
| Risk variants | Some common variations raise the probability rather than determining the outcome. Finding one in a person with ALS does not mean it caused their disease |
| Incomplete penetrance | Carrying a variant associated with ALS does not mean the disease will develop. This is why predictive testing in healthy relatives is handled with genetic counselling rather than as a routine test |
| Why testing is done | Information for relatives, and eligibility for gene-directed treatments where a specific variant is found. Both are discussed with counselling |
Two things are worth stating to anyone reading this after a diagnosis. A negative genetic test does not make the diagnosis any less real, and it does not change the plan. And a positive result in a sporadic case is often an incomplete explanation rather than a cause that can be removed.
What has been studied, and what has been established
The distinction in this section matters more than any individual finding, because the gap between the two columns is where most false hope and most unnecessary guilt live.
| Factor | What the evidence supports |
|---|---|
| Smoking | Associated with a higher rate of ALS in several studies. An association is not proof of cause, and stopping has many other reasons to recommend it — lung function chief among them in this disease |
| Occupational exposures — pesticides, solvents, metals | Studied repeatedly with inconsistent results. A plausible signal in some groups, and not established as a cause an individual can remove retrospectively |
| Very high levels of physical exertion | Investigated in athletic populations, again with inconsistent findings. Not a basis for advising anyone to stop moving |
| Head injury | Studied as a possible risk factor; results do not agree, and no causal relationship has been established |
| Military service | A signal appears in some cohorts without a mechanism that has been established |
| Mobile phones and electrical exposure | Studied and not established |
| Diet, supplements and lifestyle | No dietary cause or preventive diet has been established. Maintaining weight is important once the disease is present, which is different from prevention |
What can be said plainly: no environmental exposure has been established as a cause that a person can remove, and ALS occurs across every kind of history. The search for an explanation is understandable, and the honest answer is that for most people there is not one to find.
Who develops ALS
Most cases are sporadic, and the pattern that has been described is one of tendencies rather than of prediction.
| Factor | What it means |
|---|---|
| Age | Risk rises with age through the later decades of life. Onset in younger adults occurs and is often investigated more actively, including genetically |
| Sex | Affects men slightly more often than women in most series. The difference is small and does not help any individual |
| Family history of ALS or frontotemporal dementia | The strongest known risk factor, and the one that changes what is offered — genetic counselling, and testing discussed properly |
| A known pathogenic variant | Raises risk substantially, though not to certainty — penetrance is incomplete and varies by gene |
None of this is a prediction, and it does not change what is worth doing. Because the disease is uncommon and usually sporadic, the practical message is about recognition rather than risk: progressive painless weakness with wasting is what should bring someone to assessment, whatever their background.
What makes the course harder
Separate from cause, there is a list of things that worsen the course once the disease is present — and unlike the search for a cause, this list is actionable.
Falling weight and inadequate nutrition, which track with outcome and are addressed rather than observed. Chest infections, which are both more likely and more damaging when cough is weak, and which are treated early and thoroughly rather than at home. Aspiration from unsafe swallowing, which is prevented by assessment and by texture change rather than discovered after a pneumonia. Delay in starting breathing support, which is the commonest avoidable loss. Contracture and frozen joints from immobility, prevented by daily stretching and positioning. Smoking, which reduces the respiratory reserve this disease depends on. And poor sleep, which in ALS is frequently a breathing signal rather than a separate problem, and should be investigated as one.
Two further things belong here because they are under-rated. Social isolation worsens outcomes in every chronic neurological disease, and staying connected is a treatment rather than a nicety. And exhaustion in carers is a clinical problem, because a plan that depends on one unsupported person will fail at the point it is most needed. The living-with-ALS page turns these into a plan.